These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27231704)

  • 1. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.
    Lim NS; Swanson CR; Cherng HR; Unger TL; Xie SX; Weintraub D; Marek K; Stern MB; Siderowf A; ; ; Trojanowski JQ; Chen-Plotkin AS
    Ann Clin Transl Neurol; 2016 May; 3(5):346-55. PubMed ID: 27231704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer's Disease.
    Guan J; Wang P; Lu L; Zhao G
    Front Aging Neurosci; 2020; 12():38. PubMed ID: 32226377
    [No Abstract]   [Full Text] [Related]  

  • 5. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    Tan YJ; Siow I; Saffari SE; Ting SKS; Li Z; Kandiah N; Tan LCS; Tan EK; Ng ASL
    J Alzheimers Dis; 2023; 92(2):573-580. PubMed ID: 36776067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease.
    Fujino T; Hossain MS; Mawatari S
    Adv Exp Med Biol; 2020; 1299():195-212. PubMed ID: 33417216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease.
    Johar I; Mollenhauer B; Aarsland D
    Int Rev Neurobiol; 2017; 132():275-294. PubMed ID: 28554411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease.
    Nemcova Elfmarkova N; Gajdos M; Rektorova I; Marecek R; Rapcsak SZ
    Neuropsychologia; 2017 Nov; 106():236-244. PubMed ID: 28974380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review.
    Janoutová J; Šerý O; Hosák L; Janout V
    Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
    Chen-Plotkin AS; Hu WT; Siderowf A; Weintraub D; Goldmann Gross R; Hurtig HI; Xie SX; Arnold SE; Grossman M; Clark CM; Shaw LM; McCluskey L; Elman L; Van Deerlin VM; Lee VM; Soares H; Trojanowski JQ
    Ann Neurol; 2011 Apr; 69(4):655-63. PubMed ID: 21520231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of arterial stiffness with cognition in patients with Lewy body disorder.
    Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS
    Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
    Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
    Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
    J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.